Info

Kensey Nash Corporation is a medical device company known for product development and technology in the fields of resorbable biomaterials used in a variety of medical procedures and endovascular devices. The Company provides a range of products into multiple medical markets, primarily in the cardiovascular markets, the orthopedic markets of sports medicine, spine and extremities, and the endovascular markets. The Company sells its products through partners and do not sell direct to the end user. On May 30, 2008, the Company completed the sale of its remaining endovascular business, including the ThromCat, QuickCat and SafeCross products, to The Spectranetics Corporation.(Source: 10-K)